SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-22-009340
Filing Date
2022-04-15
Accepted
2022-04-15 16:26:18
Documents
7
Period of Report
2022-05-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A mirati2022proxy.htm DEF 14A 1357990
2 davidmeeksignature_april20.jpg GRAPHIC 10653
3 miratilogo_purple.jpg GRAPHIC 7923
4 votecard1a.jpg GRAPHIC 63448
5 votecard2a.jpg GRAPHIC 88265
6 votecard3a.jpg GRAPHIC 14882
7 votecard4a.jpg GRAPHIC 49541
  Complete submission text file 0001628280-22-009340.txt   1682815
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35921 | Film No.: 22830262
SIC: 2834 Pharmaceutical Preparations